Bumetanide for Alzheimer’s disease

Alzheimer’s disease is the most common form of dementia, affecting up to 70% of all people with dementia.1 In the early stages, symptoms can...

Spotlight on prescriber-pharmacist relationships

0
Leaders from pharmacy, medical and consumer organisations will gather in Canberra on Tuesday to explore how doctors and pharmacists can better cooperate to support...

Aged care antimicrobial prescribing on the rise

0
Data released last month shows an increase in the number of aged care residents prescribed antimicrobials, highlighting the need for pharmacists to use their...

Australian pharmacists get seat at global table

0
The international voice of Australian pharmacy has been amplified by the appointment of PSA National President Dr Shane Jackson to the International Pharmacy Federation...

New ECP Director to focus on the future

0
WA-based hospital pharmacist Lauren Burton has been appointed as the new Early Career Pharmacist (ECP) Director of PSA, effective from 1 July 2018. PSA...

Informing pharmacy practice with valuable research

0
PSA’s Pharmacists in 2023 vision advocates the implementation of a ‘research culture’ in Australia. Here’s how members can pursue valuable research in their own...